https://scholars.lib.ntu.edu.tw/handle/123456789/508253
標題: | Cost-effectiveness analysis for determining optimal cut-off of immunochemical faecal occult blood test for population-based colorectal cancer screening (KCIS 16) | 作者: | Chen L.-S. Liao C.-S. SHU-HUI CHANG HSIN-CHIH LAI Chen, Tony Hsiu Hsi |
公開日期: | 2007 | 卷: | 14 | 期: | 4 | 起(迄)頁: | 191-199 | 來源出版物: | Journal of Medical Screening | 摘要: | Objectives: We aimed to determine the optimal cut-off of the immunochemical faecal occult blood test (iFOBT) by using cost-effectiveness analysis. Methods A total of 22,672 subjects aged 50 years or older were invited to have an uptake of iFOBT. We collected data from screen-detected cases for the cut-off above 100 ng/mL and obtained interval cancers from a nationwide cancer registry for a cut-off below 100 ng/mL. We found a total of 65 colorectal cancer (CRC) cases, including 43 detected by screen and 22 diagnosed between screens (interval cases). The optimal cut-off was first determined by receiver operating characteristics (ROC) curve analysis. Formal economic evaluation was further applied to identifying the optimal cut-off by assessing the minimum incremental cost-effectiveness ratio (ICER), an indicator for cost per life year gained (effectiveness), given a series of cut-offs of iFOBT, ranging from 30 to 200 ng/mL compared with no screening. Results: ROC curve analysis found the optimal cut-off of iFOBT to be 100 ng/mL at which the sensitivity, false-positive and odds of being affected given a positive result were 81.5% (70.2%-89.2%), 5.7% (5.4%-6.0%) and 1.24 (1.19-1.32), respectively. The area under ROC curve was 0.87 (0.81-0.93). In economic appraisal, the screening programme irrespective of any cut-off dominated (less cost and more effectiveness) over the control group. The optimal cut-off (the lowest ICER) was 110 ng/mL at which an average of 0.054 life year was gained and that of 950 ($US) was saved. Conclusions: We used cost-effectiveness to identify 110 ng/mL as the optimal cut-off of iFOBT in a Taiwanese population-based screening for CRC. Our model provides a useful approach for health policy-makers in designing population-based screening for CRC to determine the optimal cut-off of iFOBT when cost and effectiveness need to be taken into account. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/508253 | ISSN: | 0969-1413 | DOI: | 10.1258/096914107782912022 | SDG/關鍵字: | adult; aged; article; blood examination; cancer diagnosis; cancer patient; cancer registry; colorectal cancer; controlled study; cost effectiveness analysis; decision making; female; health care policy; human; immunochemistry; major clinical study; male; occult blood; receiver operating characteristic; Aged; Aged, 80 and over; Algorithms; Colorectal Neoplasms; Cost-Benefit Analysis; Decision Trees; Female; Humans; Immunochemistry; Male; Mass Screening; Middle Aged; Occult Blood; Population; Reference Values; ROC Curve |
顯示於: | 醫學檢驗暨生物技術學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。